D.E. Shaw & Co’s Allergan Inc AGN Stock Holding History

D.E. Shaw & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,757,200	Closed	-$374M	–	4399
2014 Q4	$374M	Buy	1,757,200 +646,489	+58%	+$129M	0.48%	24
2014 Q3	$198M	Buy	1,110,711 +356,019	+47%	+$59.1M	0.26%	65
2014 Q2	$128M	Buy	754,692 +9,489	+1%	+$1.48M	0.17%	110
2014 Q1	$92.5M	Buy	745,203 +533,015	+251%	+$64.9M	0.13%	153
2013 Q4	$23.6M	Sell	212,188 -282,222	-57%	-$27M	0.03%	595
2013 Q3	$44.7M	Buy	494,410 +67,251	+16%	+$6.04M	0.07%	297
2013 Q2	$36M	Buy	+427,159	New	+$44.3M	0.07%	318

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

D.E. Shaw & Co's AGN Position: Q1 2015 in Review

D.E. Shaw & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,757,200 shares — an estimated $374M sold.

D.E. Shaw & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $374M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

D.E. Shaw & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
D.E. Shaw & Co sold 1,757,200 Allergan Inc shares in Q1 2015, an estimated $374M.
D.E. Shaw & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
D.E. Shaw & Co's Allergan Inc position peaked at $374M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.